Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
(2025, Nature Metabolism ) reported daLUXendin and daLUXendin+, non-lipidated and lipidated dual GLP-1/GIP receptor agonist fluorescent probes with nanomolar affinity at both hGLP1R and hGIPR
Health Savings and Flexible Spending Accounts: Tax-advantaged accounts let employees apply pre-tax dollars to eligible weight management expenses, further supporting individualized choice
When we eat, GLP-1 is released, signaling our brain to reduce hunger and make us feel full
Lancet Diabetes Endocrinol 13, 15-28 (2025)
doi: 10.1038/nrcardio.2011.211 35 DegnKBBrockBJuhlCBDjurhuusCBGrubertJKimDet al
What makes it different: Once daily, any time of day No empty stomach requirement No waiting period before eating or drinking No refrigeration needed In clinical trials, the highest dose produced an average weight loss of around 11 percent over 72 weeks in adults without diabetes
US$ 25.68
US$ 24.93
US$ 29.57
US$ 29.22
US$ 22.62
US$ 27.34
US$ 25.24
US$ 23.89
US$ 20.55
US$ 26.02
US$ 24.28
US$ 25.97
US$ 22.16
